Department of Health Home A to Z Topics About the Department of Health Site Map Contact Us - Opens in a new window

Epidemiology Home

Health Topics (A-Z)

Related Links

Contact Us

   

Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

For August 2, 2000

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jill H. Parker, MSP, Epi Update Editor

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

William J. Bigler, PhD, MS,

Senior Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

In this issue:

1. Satellite Teleconference Announcement: Introduction to the Merlin Web-based Reporting System

2. County Health Department Assistance Requested to Recruit Physicians for the National Influenza Sentinel Physicians’ Surveillance Network

3. Investigation of Multi-state Clusters of E. coli O157:H7 Cases

4. Weekly Arbovirus Activity Summary

5. Summary Report: Influenza Activity in Florida, 1999-2000 Season

6. Surgeon General Media Advisory on Hepatitis C

7. Three Lots of Imovax Rabies Vaccine Recalled

8. Bureau of Epidemiology "One-Pager" Series: Norwalk-like Viral Gastroenteritis

9. Internet Link: International Conference on Emerging Infectious Disease (ICEID)

10. Weekly Disease Table: Week 30


1. Satellite Teleconference Announcement: Introduction to the Merlin Web-based Reporting System

Title: Introduction to the Merlin Web-based Disease Reporting System

Date: August 14, 2000

Time: 2 – 4 PM EST

Satellite Test: 1:30 PM – 2:00 PM

Target Audience: County health department disease reporting and epidemiology staff

Objective: To introduce the Merlin web-based disease reporting system to county health department staff that report communicable disease data to the Bureau of Epidemiology.

Description:

The purpose of this teleconference is to introduce county health department disease reporting and epidemiology personnel to the Merlin web-based disease reporting system, which will be up and running in every county health department beginning January 1, 2001. The Merlin system will become the standard disease reporting system for the Bureau of Epidemiology, replacing the current paper-based disease reporting system. Participants will be guided through the system at its current stage of development and will have an opportunity for a question and answer session. Extensive training will be provided in future sessions to be announced.

Registration: Please register with your local satellite site coordinator by August 11, 2000. A list of the site coordinators for each county is posted on the Department of Health Intranet web site (go to Office of Performance Improvement, then click on "training").

2. County Health Department Assistance Requested to Recruit Physicians for the National Influenza Sentinel Physicians’ Surveillance Network

Carina Blackmore, MS Vet.Med., PhD, Bureau of Epidemiology

It is time to start recruiting physicians for the 2000-2001 National Influenza Sentinel Physicians’ Surveillance Network. We need pediatricians and other primary care physicians who are interested and willing to:

  1. Report clinical cases of influenza-like illness to CDC on a weekly basis between October 2000-May 2001
  2. Submit throat swabs (free of charge) to our state labs for virus isolation testing.

Goals of the surveillance program are to better monitor the morbidity of disease locally and nationally; to collect influenza virus strains for vaccine development and to monitor the patterns of antigenic drift/ shift (mutations); and to detect potential pandemic influenza strains and possible bio-terrorist agents that cause respiratory symptoms.

3. Investigation of Multi-state Clusters of E. coli O157:H7 Cases

Mike Friedman, M.P.H., Roberta Hammond, Ph.D., Bureau of Environmental Epidemiology

During the last few weeks, increasing numbers of E. coli O157:H7 cases have been reported throughout Florida. None of these cases has resulted in hemolytic-uremic syndrome (HUS). Twenty-six cases of E. coli O157:H7 have been reported recently with onsets of symptoms dating from June 25, 2000 to July 18, 2000. Florida has been averaging approximately 23 cases of E. coli O157:H7 per year. The molecular biology section of the Bureau of Laboratories in Jacksonville, has identified matching Pulse Field Gel Electrophoresis (PFGE) patterns among a cluster of six E. coli cases and another matching pattern among a cluster of four other E. coli cases.

There has not been any geographic clustering of reported cases of E. coli O157:H7 in the state. Cases seem to be scattered throughout Florida, including those with matching PFGE patterns. Ages of cases range from 5 to 91 years. Five of the six cases of E. coli with matching patterns had reported ground beef consumption a few days before their onset of symptoms; exposure to canteloupe has also been identified in the one case. Hamburger and ground beef exposure have been the most common food vehicles identified through case investigation. A second cluster of four E. coli cases with a different matching PFGE pattern has since been identified. Only limited information is available at this time on the one case reporting consumption of canteloupe.

PFGE patterns were sent out through the PulseNet Computer Network by Paul Fiorella, Bureau of Laboratories. PulseNet provides a forum for public health laboratories to share information that will help rapidly identify and stop episodes of foodborne illness. Matching PFGE patterns have also been identified by seven other states including: New York, Colorado, Minnesota, Wisconsin, California, Connecticut and Washington. Additional PFGE enzyme analysis is being performed by each state to ensure that the identified E. coli clusters are true matches.

According to the Centers for Disease Control and Prevention (CDC), forty cases of E. coli O157:H7 with matching PFGE patterns have been recently identified in eight states. Onset dates of cases have ranged from May 7, 2000 to July 11, 2000. The ages of cases range from 8 months to 93 years, with a median age of 20 years. The most commonly identified food vehicles have been ground beef & cantaloupe. Several of the cases purchased food items from one of two grocery store chains, however the significance of these data is not clear at this time.

The Connecticut and California Departments of Health have developed an E. coli questionnaire to better understand the recent E. coli clusters. The questionnaires are designed to collect extended food and water histories of E. coli O157:H7 matching cases.

There is also an E. coli O157:H7 PFGE matching pattern reported among 4 or 5 states at this time. This PFGE pattern does not match any Florida cases and only very limited surveillance information is available on these cases.

4. Summary Report: Influenza Activity in Florida, 1999-2000 Season

Carina Blackmore, MS Vet. Med., PhD, Bureau of Epidemiology

Influenza activity in Florida last winter began to increase in mid-December 1999 and peaked during the week ending January 7, 2000 (week 1). The percentage of influenza-like illness (ILI) patient visits to physicians participating in the influenza sentinel surveillance network increased above baseline levels (0-3%) 3 of the 4 weeks following the week ending December 18 (week 50) (Figure 1).

Twenty-seven percent of the specimens cultured in our state laboratories (n=522) were positive for influenza. Most (97%) of the isolates were influenza A/H3N2/ Sydney, however influenza A/H1N1 and influenza B were also isolated (Figure 1, Figure 2).

Fifty-three clinics in 24 Florida counties participated in the influenza sentinel surveillance network last year (Figure 2, Figure 3). The goal of this program is to have 1 sentinel physician/ 250,000 Florida residents, a goal we hope to achieve during the 2000-2001 season.

Sporadic outbreaks of influenza (regional activity) were reported to the state health office during weeks 52-2.

Influenza activity in Florida corresponded well with the influenza activity nationwide. Based on genetic testing of virus strains CDC concluded that overall, the 1999-2000 influenza vaccine strains were well matched to circulating influenza virus strains. However, worldwide influenza A\H1N1\New Caledonia and A\H3N2\Panama were more prevalent than last years vaccine strains (A\H1N1\Bayern and A\H3N2\Sydney) and will replace last years strains in the 2000-2001 influenza vaccine.

5. Weekly Arbovirus Activity Summary

Robin Oliveri, Arbovirus Surveillance Coordinator and Lisa Conti, DVM, MPH, State Public Health Veterinarian

There are currently no Arbovirus Medical Alerts issued for the state. During the period 7/22/00 through 7/29/00, the following arbovirus* activity was recorded for Florida:

(*Mosquito-borne virus including St. Louis encephalitis virus, Eastern Equine encephalitis virus, West Nile encephalitis virus and dengue virus)

Human: No new arbovirus cases were reported to the State Health Office.

Sentinel chickens: No sentinel chicken seroconversions were identified (611 chickens tested).

Equine: No horses were reported with arboviruses. (Source: Department of Agriculture and Consumer Services Laboratory from veterinarians)

Bird Mortality: 7 dead birds were reported from the following counties: Bay-6 other, Broward-1 dove. Although we are collecting information about any dead bird, at this time, the DOH is testing crows that have died within 24 hours prior to report. To date, 4 crows have been tested and none were found to have arboviruses. (Source: Florida Fish and Wildlife Conservation Commission website.

Mosquito Pools: No mosquito pools were tested for arboviruses during this period. (Source: DOH Laboratory and mosquito control agencies).

6. Surgeon General Media Advisory on Hepatitis C

Bonnie Kwan, MPH, Hepatitis Program Coordinator and Steven Wiersma, MD, MPH, Deputy State Epidemiologist

The Surgeon General, Dr. David Satcher, issued a media advisory on Thursday, July 27, 2000 on hepatitis C. Hepatitis C, often referred to as the "Silent Epidemic", is believed to affect approximately four million Americans, which is four times the number of HIV infections nationally. In Florida, this translates to more than 270,000 hepatitis C infections. This advisory will be used to disseminate prevention recommendations on hepatitis C.

According to the recommendations published by the Centers for Disease Control and Prevention, the following individuals are at increased risk of hepatitis C and are urged to get tested: injection drug users (even once); transfusion or transplant recipients (prior to July 1992); recipients of a blood product for clotting problems produced before 1987; individuals on long-term kidney dialysis; individuals who have received needle sticks contaminated with HCV-infected blood; and individuals born to an HCV-positive mother.

The Florida legislature recognized the importance of viral hepatitis and supported the development of a comprehensive hepatitis and liver failure control and prevention program. Testing is available through the state laboratory and a contract for a state-wide hotline with additional home-based testing will be finalized soon.

7. Three Lots of Imovax Rabies Vaccine Recalled

(Excerpted from IAC Express #178 published by the Immunization Action Coalition)

The Centers for Disease Control and Prevention (CDC) published a "Notice to Readers" in the July 28, 2000, issue of the MMWR entitled "Voluntary Recall of IMOVAX

Rabies I.D. (Rabies Vaccine) Used for Pre-Exposure Prophylaxis." The notice reads as follows:

Through routine stability testing, Aventis Pasteur recently learned that the potency of one lot of IMOVAX Rabies I.D. (Rabies Vaccine), used as an alternative to rabies vaccine administered intramuscularly for pre-exposure prophylaxis, had fallen below specification 24 months after manufacturing. Although this product met all specifications at the time of release, its potency fell below specification before the product's expiration date. Only lot P0313-2 was involved; however, lots P0030-2 and N1204-2 also are being recalled as a precautionary measure. All three lots were prepared from the same initial bulk lot.

To help ensure all persons who received a vaccination from one of the recalled lots are alerted, the company is contacting all customers who received a shipment of the

recalled lots. A toll-free telephone number also has been set up for medical inquiries about the recall, (800) 752-9340.

Persons who received pre-exposure vaccination for rabies should contact their health-care provider to determine whether they should be revaccinated.

As a precaution, patients who were vaccinated with one of these lots for pre-exposure prophylaxis--and who remain at risk for rabies exposure--should either be tested to measure the presence of antibodies and be vaccinated as needed (if the testing will not substantially delay vaccination), or be revaccinated. Aventis Pasteur recommends that patients being revaccinated receive one dose of IMOVAX Rabies, Rabies Vaccine for intramuscular (IM) use.

8. Bureau of Epidemiology "One-Pager" Series: Norwalk-like Viral Gastroenteritis

Zuber D. Mulla, MSPH, Bureau of Epidemiology, and Lillian Stark, PhD, MS, MPH, Bureau of Laboratories

Norwalk-like viruses (NLV) are the most common cause of epidemic gastroenteritis in the United States [1]. Each year, approximately 23 million persons develop NLV gastroenteritis in the United States [1]. NLV gastroenteritis (also known as "winter vomiting disease") is usually a self-limiting, mild to moderate disease [2]. Persons of all ages are affected because previous infection confers only short-term immunity [1].

Signs and symptoms can include diarrhea, vomiting, abdominal pain, nausea, headache, and low-grade fever [2]. NLV are small, structured RNA viruses classified as caliciviruses. The incubation period is approximately 24 to 48 hours. Gastrointestinal symptoms last 24 to 48 hours. The likely mode of transmission is the fecal-oral route. NLV have been implicated in foodborne outbreaks and outbreaks where the mode of transmission was person-to-person [1,3]. The virus may be shed in feces up to 48 hours after recovery. Airborne transmission is also possible.

Humans were previously thought to be the only reservoir of NLV [2], but a recent report suggests that farms animals can also harbor these agents also [4]. Zoonotic transmission has not been documented.

Outbreaks of NLV gastroenteritis are often seen in long-term care facilities and other institutions where people live in close proximity. Facility staff should practice good hygiene including hand washing before and after contact with residents and guests. Hands are the most likely means by which viral spread occurs and therefore should be washed after contact with ill persons or contaminated clothing. Wearing masks when cleaning up diarrhea and vomitus of ill residents or handling soiled linen may prevent inhalation of droplet nuclei to which the virus is attached. Soiled linen should be transported in an enclosed manner, for example, in a plastic bag, and agitation of the linen should be kept to a minimum. For more information please refer to Morbidity and Mortality Weekly Report Volume 39, No. RR-5: Viral Agents of Gastroenteritis Public Health Importance and Outbreak Management.

Other recommendations:

  1. Staff and visitors who are ill should remain at home
  2. Do not move ill residents to other parts of the facility
  3. Do not allow staff to work on more than one wing
  4. Cancel communal activities for the duration of the outbreak

The Bureau of Laboratories (Tampa Branch) offers polymerase chain reaction (PCR) testing of stool specimens for NLV (see January 13, 1999, issue of the "Epi Update"). Stool should only be collected from acutely ill individuals or individuals who have recovered within the past two days. Please contact your Regional Epidemiologist from the Bureau of Epidemiology for information on the collection and shipment of stool for Norwalk testing.

References

  1. Centers for Disease Control and Prevention. Outbreaks of Norwalk-like Viral Gastroenteritis – Alaska and Wisconsin, 1999. Morbidity and Mortality Weekly Report 2000;49:207-211.
  2. Chin J (ed.). Control of Communicable Diseases Manual, 17th edition. United Book Press: Baltimore; 2000, pp. 218-220.
  3. Arness MK, et al. Norwalk-Like Viral Gastroenteritis Outbreak in U.S. Army Trainees. Emerging Infectious Diseases. March-April 2000.
  4. van der Poel WHM et al. Norwalk-Like Calicivirus Genes in Farm Animals. Emerging Infectious Diseases. January-February 2000.

9. Internet Link: International Conference on Emerging Infectious Disease (ICEID), Atlanta, July 16-19, 2000

Kathryn Snavely, Bureau of Epidemiology

Click on the link below to access selected presentations and panels from the recent International Conference on Emerging Infectious Diseases.

10. Weekly Disease Table: Week 30

County-Confirmed Cases, Sorted Alphabetically by Disease

(NR represents years that the disease lacked status as a reportable condition)

DISEASE

1997 TO DATE

1998 TO DATE

1999 TO DATE

3 YEAR AVERAGE

TO DATE

1999 TOTAL CASES

2000 TO DATE

Anthrax

0

0

0

0

0

0

Botulism

0

0

0

0

4

0

Brucellosis

0

1

0

0.3

3

2

Campylobacteriosis

536

413

502

483.7

988

522

Ciguatera

2

6

2

3.3

2

1

Cryptosporidiosis

57

68

65

63.3

180

38

Cyclosporiasis

57

5

2

21.3

5

3

Dengue

1

1

2

1.3

3

1

Diphtheria

0

0

0

0

0

0

E. coli O157:H7

31

18

26

25

54

36

E. coli, other (known serotype)

5

2

12

6.3

16

8

Ehrlichiosis, Human

2

0

1

1

2

3

Encephalitis, Eastern Equine

0

0

0

0

3

0

Encephalitis, St. Louis

0

0

0

0

4

0

Encephalitis, other (known organism)

6

3

2

3.7

5

4

Encephalitis, post-infectious1

5

5

4

4.7

14

5

Giardiasis (acute)

772

674

552

666

1322

637

Haemophilus influenzae, invasive1

12

26

29

22.3

53

30

Hansen’s Disease (Leprosy)

0

3

2

1.7

3

1

Hantavirus Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

2

3

6

3.7

7

6

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

245

286

359

296.7

796

261

Hepatitis B

205

209

223

212.3

528

255

Hepatitis C

NR

NR

28

NR

56

21

Hepatitis Non-A, Non-B

51

50

3

34.7

12

6

Hepatitis, perinatal B

NR

NR

1

NR

 

2

Hepatitis, unspecified

3

5

9

1

17

6

Hepatitis, +HBsAg, pregnant woman

NR

NR

8

NR

245

227

Lead Poisoning

755

937

938

876.7

1822

429

Legionellosis

14

21

13

16

27

27

Leptospirosis

0

1

0

0.3

1

1

Listeriosis

NR

NR

12

NR

38

12

Lyme Disease

13

20

11

14.7

50

16

Malaria

40

31

47

39.3

97

48

Measles

3

2

1

2

2

1

Meningococcal Disease (N. meningitidis)

95

80

68

81

122

70

Meningitis, Group B Streptococci

10

11

8

9.7

14

10

Meningitis, Haemophilus influenzae1

6

9

10

8.3

13

3

Meningitis, Streptococcus pneumoniae

51

55

66

57.3

98

54

Meningitis, Listeria monocytogenes

2

4

5

3.7

14

4

Meningitis, other bacterial (including unspecified)

31

33

32

32

61

55

Mercury Poisoning

2

0

2

1.3

7

7

Mumps

8

9

2

6.3

6

2

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

42

23

43

36

86

35

Pesticide Related Illness and Injury2

0

1

1

0.7

32

3

Plague

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

1

0

0.3

0

0

Q Fever2

NR

NR

NR

NR

0

0

Rabies, Animal

176

119

101

132

186

82

Rocky Mountain Spotted Fever

2

1

2

1.7

2

0

Rubella, including congenital

0

3

0

1

1

3

Salmonellosis

942

1054

1176

1057.3

3071

1099

Shigellosis

620

1140

777

845.7

1491

734

Smallpox

NR

NR

0

NR

0

0

Staphylococcus aureus, (GISA/VISA)

NR

NR

0

NR

0

0

Staphylococcus aureus, (GRSA/VRSA)

NR

NR

0

NR

0

0

Streptococcal Disease, invasive Group A

24

27

38

29.7

94

76

Streptococcus pneumoniae, invasive disease

125

284

331

246.7

701

643

Tetanus

0

2

1

1

3

0

Toxoplasmosis

3

6

8

5.7

17

6

Typhoid Fever

5

10

21

12

23

6

Vibrio cholerae (serogrp O1)

0

0

0

0

0

0

Vibrio cholerae (serogrp Non-O1)

6

6

5

5.7

10

4

Vibrio vulnificus

6

13

6

8.3

23

2

Vibrio other (including unspecified)

19

43

24

28.7

48

18

Yellow Fever

0

0

0

0

0

0

1 Haemophilus influenzae can be the agent responsible for disease under three of the reportable conditions listed-: "Haemophilus influenzae, invasive" and under "Encephalitis, post infectious." Cases of Haemophilus influenzae meningitis are reported under "Meningitis, H. influenzae."

2 The reportable disease rule was revised in June 2000. Amebiasis and Toxic Shock Syndrome (Staphylococcal and Streptococcal) were deleted from the list of reportable diseases. Q Fever was added to the list of reportable diseases. Pesticide poisoning is now referred to as pesticide related illness and injury.

 

 

This page was last modified on: 10/29/2012 02:30:25